3rd ESO Prostate Cancer Observatory: innovation and care in the next 12 months
Not eligible for ESCO credits
11.03.2016
Munich, Germany
COURSES AND SEMINARS
Description
Chairs: S. Joniau, BE - R. Valdagni, IT
The European School of Oncology is pleased to announce the 3rd edition of "ESO Prostate Cancer Observatory: innovation and care in the next 12 months", which will be held during the EAU16 Congress on March 11 in Munich, chaired by Prof. H. van Poppel and Prof. R. Valdagni.
AIMS AND OBJECTIVES
ESO Observatories are high level sessions organised during major international congresses with the aim of providing the audience with updated and unbiased information on a given topic. An ESO Observatory lasts about one hour and concentrates on a forecast given by panel of experts of what it is expected to happen in their own field in the coming 12 months. The Panel includes distinguished clinicians and/or scientists and a patient advocate.
The forecast by each Panel Member is given in the form of take-home concise messages with 7 minute slide presentation followed by 3 minutes of discussion for each topic. The forecast will be discussed by the panel.
| The Observatory will be held during the | ||||||
 | ||||||
Under the auspices of | ||||||
 |
.
General information
ESO SECRETARIAT
Rita De Martini- Prostate Cancer Programme
European School of Oncology
Via Turati 29, 20121, Milan, Italy
Email: prostate@eso.net
Tel: +39 02 85464527
VENUE
The Observatory will be held during the EAU Annual Congress.
9:45-11:30
Room 11 - ICM Level 1
ICM – Internationales Congress Center München
Messe München
Messegelände
81823 München
Germany
T: +49 89 949-20720
www.icm-muenchen.de
www.messe-muenchen.de
Faculty list
PANELISTS
F. Claessens, Leuven, BE
G. De Meerleer, Ghent, BE
M. Emberton, London, UK
K. Goffin, Leuven, BE
K. Mastris, Clayhall Ilford Essex, UK
R. Montironi, Ancona, IT
S. Osanto, Leiden, NL
D. Sjoberg, New York, US
K. Touijer, New York, US
Programme
11 March
| 9:45 | Introduction | |
| 9:50 | The researcher’s perspective F. Classens, BE | |
| 10:00 | The urologist’s perspective on screening K. Touijer, US | |
| 10:10 | The biostatistician/methodologist D. Sjoberg, US | |
| 10:20 | The imaging specialist’s perspective on MRI M. Emberton, UK | |
| 10:30 | The pathologist’s perspective R. Montironi, IT | |
| 10:40 | The radiation oncologist’s perspective G. De Meerleer, BE | |
| 10:50 | The medical oncologist’s perspective S. Osanto, NL | |
| 11:00 | The imaging specialits’s perspective on PSMA K. Goffin, BE | |
| 11:10 | The patient’s perspective K. Mastris, UK | |
| 11:20 | Discussion and take home messages | |